2011
DOI: 10.1016/j.clinbiochem.2011.09.011
|View full text |Cite
|
Sign up to set email alerts
|

A cross-sectional study of the association between heat shock protein 27 antibody titers, pro-oxidant–antioxidant balance and metabolic syndrome in patients with angiographically-defined coronary artery disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 23 publications
(10 citation statements)
references
References 45 publications
0
10
0
Order By: Relevance
“…The existence of AAB against HSPs in the context of atherosclerosis is not new – for example, antibodies generated against microbial HSP60 may cross-react with endogenous HSP60 expressed in the vessel lumen (molecular mimicry), enhancing inflammation and promoting atherosclerosis ( 173 ). HSP27 AAB are present in other disease states like cancer ( 174 ) and acute heart disease ( 175 177 ), although it is difficult to gage how levels correlate with disease. Higher antibody titers are associated with improved survival of breast cancer patients, but elevations also correlate with adverse conditions, such as metabolic syndrome ( 177 ) and the early phase of acute coronary syndromes (e.g., myocardial infarction and unstable angina) – although in acute coronary syndromes, HSP27 antibody levels rapidly fall after a brief spike ( 175 ).…”
Section: Future Directionsmentioning
confidence: 99%
See 1 more Smart Citation
“…The existence of AAB against HSPs in the context of atherosclerosis is not new – for example, antibodies generated against microbial HSP60 may cross-react with endogenous HSP60 expressed in the vessel lumen (molecular mimicry), enhancing inflammation and promoting atherosclerosis ( 173 ). HSP27 AAB are present in other disease states like cancer ( 174 ) and acute heart disease ( 175 177 ), although it is difficult to gage how levels correlate with disease. Higher antibody titers are associated with improved survival of breast cancer patients, but elevations also correlate with adverse conditions, such as metabolic syndrome ( 177 ) and the early phase of acute coronary syndromes (e.g., myocardial infarction and unstable angina) – although in acute coronary syndromes, HSP27 antibody levels rapidly fall after a brief spike ( 175 ).…”
Section: Future Directionsmentioning
confidence: 99%
“…HSP27 AAB are present in other disease states like cancer ( 174 ) and acute heart disease ( 175 177 ), although it is difficult to gage how levels correlate with disease. Higher antibody titers are associated with improved survival of breast cancer patients, but elevations also correlate with adverse conditions, such as metabolic syndrome ( 177 ) and the early phase of acute coronary syndromes (e.g., myocardial infarction and unstable angina) – although in acute coronary syndromes, HSP27 antibody levels rapidly fall after a brief spike ( 175 ). It is still unclear how HSP27 AAB are linked to CVD – one study correlated elevations with CVD ( 176 ), while other findings indicate the opposite, that HSP27 autoantibody titers ( 67 , 178 ) are higher in healthy control subjects compared to CVD patients.…”
Section: Future Directionsmentioning
confidence: 99%
“…An in‐house ELISA assay was applied to determine serum anti‐Hsp27 levels as described previously (Sahebkar et al ., ). In brief, microtitre plates were coated with recombinant human Hsp27.…”
Section: Methodsmentioning
confidence: 97%
“…Hsp27 is a member of the small Hsp family that is constitutively expressed in many cell types including cardiomyocytes and endothelial cells (Tucker et al ., ; Gernold et al ., ; Pauli et al ., ). Several investigations have reported an elevation of circulating levels of Hsp27 and its corresponding antibodies (anti‐Hsp27) with coronary artery disease (CAD) (Pourghadamyari et al ., ), acute coronary syndrome (ACS) (Heidari‐Bakavoli et al ., ; Ghayour‐Mobarhan et al ., ) and metabolic syndrome (Sahebkar et al ., ).…”
Section: Introductionmentioning
confidence: 97%
“…An in-house ELISA assay was used to quantify serum anti-Hsp27 levels as described previously (Sahebkar et al, 2011). Briefly, serum was diluted with 2% goat serum in PBS was added to microplates which were coated with recombinant human HSP27.…”
Section: Laboratory Measurementsmentioning
confidence: 99%